Loading
Uremic pruritus — chronic itching in advanced CKD and dialysis. Why it happens (uremic toxins, dry skin, nerve sensitization) and the modern treatments that work.
Evidence reviewed & updated: 2026-08 — reflects the latest published trials and guidelines.
Chronic itching affects roughly 40-70% of dialysis patients — and it's one of the most under-treated symptoms in kidney care. The itch is driven by uremic toxins, dry skin, and nervous-system sensitization, not 'dry skin alone.' Treatments now include emollients, gabapentin/pregabalin, and difelikefalin — a drug developed specifically for uremic pruritus.
Uremic pruritus isn't 'just dry skin' — it's a multi-mechanism symptom of kidney failure: retained uremic toxins sensitize nerve endings, dry skin (xerosis) worsens it, and calcium/phosphate imbalance contributes. Dialysis removes some toxins but not all — which is why itching persists for many despite adequate treatment.
It's underestimated: many patients don't report it, and many clinicians don't ask. Studies consistently show itch strongly degrades sleep and quality of life.
Skin care first: emollients, lukewarm (not hot) showers, mild cleansers, and avoiding wool/irritants — helps but rarely cures. Then the evidence-backed agents: gabapentin or pregabalin at reduced (renal-dosed) amounts work well for many; antihistamines are common but have weak evidence in uremic itch.
Difelikefalin — a kappa-opioid agonist given intravenously during dialysis — was approved specifically for moderate-to-severe uremic pruritus and reduced itch in trials. Older options include nalfurafine (outside the US), topical agents, and UV-B phototherapy in refractory cases.
Optimize the obvious: dialysis adequacy (Kt/V), phosphate control, and treat severe secondary hyperparathyroidism — all can reduce itch. If the itch starts with a new rash, jaundice, weight loss, or fever, it's not uremic pruritus — other causes (liver disease, hematologic disease, allergies) need evaluation.
For CKD patients not yet on dialysis: itch can appear from stage 4, and the same emollient-first strategy applies.
Restless legs syndrome affects up to 20-25% of dialysis patients — several times the general population rate. The mechan...
Learn morePost-dialysis fatigue affects a large share of dialysis patients — exhaustion lasting hours to a day after treatment. It...
Learn moreMost dialysis patients sleep poorly — insomnia, sleep apnea, and restless legs all run far above population rates. The r...
Learn moreDepression is the most common complication nobody screens for: it affects roughly a third of dialysis patients — higher ...
Learn moreZuvFlo is ready to integrate with your facility to streamline operations, automate compliance, and deliver better patient care.
No credit card required • Setup in under 2 hours • Cancel anytime
Advertisement